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Abstract
Interleukin (IL)-6 is released from skeletal muscle (SkM) during exercise and
has been shown to affect hepatic metabolism. It is, however, unknown
whether SkM IL-6 is involved in the regulation of exercise training-induced
counteraction of changes in carbohydrate and lipid metabolism in the liver in
response to high-fat diet (HFD) feeding. Male SkM-specific IL-6 KO (MKO)
and Floxed mice were subjected to Chow diet, HFD or HFD combined with
exercise training (HFD ExTr) for 16 weeks. Hepatic phosphoenolpyruvate car-
boxykinase (PEPCK) protein content decreased with both HFD and HFD
ExTr in Floxed mice, but increased in IL-6 MKO mice on HFD. In addition,
the intrahepatic glucose concentration was in IL-6 MKO mice higher in HFD
than chow. Within HFD ExTr mice, hepatic glucose-6-phosphatase (G6Pase)
36 kDa protein content was higher in IL-6 MKO than Floxed mice. Hepatic
pyruvate dehydrogenase kinase (PDK) 4 and PDK2 protein content was in
Floxed mice lower in HFD ExTr than Chow. In addition, hepatic ACC1-phos-
phorylation was higher and ACC1 protein lower in HFD. Together this sug-
gests that SkM IL-6 regulates hepatic glucose metabolism, but does not seem
to be of major importance for the regulation of oxidative capacity or lipogen-
esis in liver during HFD or HFD combined with exercise training.
Introduction
It has been shown that hepatic triglyceride (TG) content
is increased when rodents are fed a high-fat diet (HFD)
(Rector et al. 2008; Gollisch et al. 2009) and is higher in
obese than lean human subjects (Fabbrini et al. 2010).
Such accumulation of intracellular lipids has been sug-
gested to induce hepatic insulin resistance and reduce
hepatic oxidative capacity (Gollisch et al. 2009), poten-
tially leading to metabolically related diseases.
Physical activity has been shown to prevent HFD-
induced development of metabolic diseases (Rector et al.
2008; Gollisch et al. 2009). Although regulation of skeletal
muscle (SkM) metabolism contributes to the exercise
training-induced counteraction of HFD feeding, the liver
has also been reported to respond to exercise training
(Rector et al. 2008; Gollisch et al. 2009), with potential
effects on whole body metabolism. Hence, it has been
shown that liver phosphoenolpyruvate carboxy kinase
(PEPCK), cytochrome c, and cytochrome c oxidase
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subunit 1 (COX1) protein content increased with exercise
training in mice on a chow diet (Haase et al. 2011). In
addition, hepatic acetyl-CoA carboxylase (ACC) protein
content has been reported to decrease after exercise train-
ing in rats with fatty liver (Rector et al. 2008). Taken
together these findings suggest that fatty acid (FA) uptake
into mitochondria as well as oxidative and gluconeogenic
capacity in the liver is increased with exercise training
indicating that exercise training may rectify the hepatic
metabolic imbalance caused by HFD. However, the
potential endocrine mechanisms underlying the exercise
training-induced improvements in hepatic metabolism are
unclear.
The plasma concentration of interleukin (IL)-6
increases during exercise (Ostrowski et al. 1998; Steens-
berg et al. 2000; Pedersen et al. 2011) and IL-6 has been
suggested to exert effects in various tissues including the
liver (Adser et al. 2011; Pedersen et al. 2011; Brandt et al.
2012; Knudsen et al. 2014, 2015). Thus, infusion of IL-6
in humans during low-intensity exercise has been shown
to increase glucose rate of appearance (Febbraio et al.
2004). In accordance, a single injection of IL-6 in rats has
been reported to increase hepatic PEPCK mRNA content
(Banzet et al. 2009), whereas another study demonstrated
that exercise-induced mRNA responses of gluconeogenic
enzymes was maintained in IL-6 knockout (KO) mice
(Fritsche et al. 2010). In addition, a study has shown that
IL-6 KO mice on HFD have reduced hepatic 3-hydroxya-
cyl-CoA dehydrogenase (HAD) activity, reduced carnitine
palmitoyl transferase 1 (CPT1) mRNA and reduced pro-
tein content of the respiratory chain complexes compared
with wild-type (WT) mice on HFD (Matthews et al.
2010). Taken together this indicates that IL-6 is central in
the regulation of lipid metabolism and oxidative capacity
in liver and suggests that IL-6 may be required for exer-
cise training-induced adaptations in liver metabolism.
However, the role of SkM IL-6 in the regulation of liver
metabolism in response to exercise training remains
unknown. Thus, this study was performed to test the
hypothesis that SkM IL-6 is required for the exercise
training-induced counteraction of HFD-associated
changes in carbohydrate metabolisms and lipid storage in
the liver.
Methods
Animals
The mice used in this experiment were fully backcrossed
C57BL6 mice carrying either a LoxP insert flanking the
second exon of the IL-6 gene (Floxed) as previously
described (Quintana et al. 2013) or IL-6 MKO mice car-
rying Cre-recombinase under the control of the myogenin
promoter (Li et al. 2005) in addition to the LoxP insert.
SkM-specific knockout of IL-6 was confirmed on genomic
DNA from SkM and liver with primers surrounding the
floxed region of the IL-6 gene (Knudsen et al. 2015).
Basal plasma IL-6 levels showed high variability and were
rarely detectable in both genotypes, and no differences
were observed between Floxed and IL-6 MKO mice (data
not shown). The SkM IL-6 mRNA content has previously
been shown to be reduced in the IL-6 MKO relative to
Floxed mice (Ferrer et al. 2014; Knudsen et al. 2015). The
mice were housed at 22°C and a 12:12 hour light: dark
cycle with ad libitum access to standard rodent chow and
water, until the onset of the experiment. Fat mass, lean
mass, and body weight as well as glucose and insulin tol-
erance and skeletal muscle IL-6 mRNA content from
these mice have previously been published (Knudsen
et al. 2015).
Ethics statement
The experiments were approved by and conducted in
accordance with guidelines provided by The Danish Ani-
mal Experiments Inspectorate (The Danish Ministry of
Foods, Agriculture and Fisheries, Denmark).
Experimental protocol
Male Floxed and IL-6 MKO mice were at the age of
8 weeks divided in three groups. A group receiving stan-
dard rodent chow (Altromin 1314F, Brogaarden, Lynge,
Denmark) (Chow), a group receiving a high-fat diet
(HFD) with 60% of calories from fat (Altromin C1090-
60, Brogaarden, Lynge, Denmark), and a group receiving
HFD in combination with having access to a running
wheel (diameter 24.2 cm, Mini-mitter) (HFD ExTr) for
16 weeks (n = 10). The running wheels were blocked
occasionally ensuring that the two exercise training
groups were running a similar distance (~ 20 km/week,
with an average pace of 26.0  1.6 m/min for Floxed and
23.7  0.4 m/min for IL-6 MKO). Additionally, to
increase the exercise load and increase adaptation to exer-
cise, HFD ExTr mice were during the last 4 weeks run-
ning on a treadmill (303401 series, TSE systems,
Germany) 60 min 3 days a week at 13.8 m/min and 10°
incline the first week increasing to 16.2 m/min and 10°
incline the last week. At the end of the experimental per-
iod, the running wheels were blocked 24 h before eutha-
nization. Ad libitum access to food and water was
maintained. The mice were euthanized by cervical disloca-
tion and livers were removed and snap frozen in liquid
nitrogen. Trunk blood was collected and centrifuged at
2600 g, 4°C for 15 min to generate plasma. All samples
were then stored at 80°C.
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Plasma metabolites
Plasma glucose and plasma lactate were measured by
enzymatic assays as previously described (Li et al. 2005)
and plasma b-hydroxybutyrate was measured using
an enzymatic kit according to manufacturer’s protocol
(# MAK041, Sigma aldrich, Copenhagen, Denmark).
Hepatic glucose, lactate, glycogen, and
triglycerides
Liver samples were crushed in liquid nitrogen and liver
glucose and lactate content was determined fluorometri-
cally (Lowry and Passonneau 1972). To determine hepatic
glycogen content, liver samples were hydrolyzed by boiling
for 2 h in 1 mol/l HCL and glycosyl units were determined
fluorometrically as previously described (Lowry and Pas-
sonneau 1972). Liver triglyceride (TG) content was mea-
sured as previously described (Norris et al. 2003). Briefly,
10 mg tissue was treated with KOH:ethanol overnight, cell
debris was removed by centrifugation, and glycerol was
measured using Free Glycerol Reagent (Sigma Aldrich,
Denmark) according to the manufacturers protocol.
Hepatic b-HAD activity
Hepatic L-3-hydroxyacyl-CoA dehydrogenase (b-HAD)
activity was measured as previously described (Essengus-
tavsson and Henriksson 1984). Briefly 10 mg of crushed
liver tissue was homogenized in 0.3 mmol/l phosphate buf-
fer containing 0.05% BSA. b-HAD activity was calculated
from the conversion of NADH to NAD in the presence of
5.87 mmol/l S-Acetoacetyl-CoA and adjusted to the pro-
tein concentration determined using the bicinchoninic acid
(BCA) assay.
RNA isolation and Reverse transcription
RNA was isolated as previously described (Chomczynski
and Sacchi 1987) with modifications (Pilegaard et al.
2000) and cDNA was produced by reverse transcribing
3 lg of RNA using superscript II reverse transcriptase
(Invitrogen, Thermofisher Scientific, Naerum, Denmark)
as previously described (Pilegaard et al. 2000).
Real time PCR
Content of specific mRNAs was determined using real-time
PCR (ABI 7900 Prism, Applied Biosystems, Foster City,
MA). Primers and Taqman Probes recognizing mouse
PGC-1a (FP: 50 CTCCCTTGTATGTGAGATCACGTT 30;
RP 50 TGCGGTATTCATCCCTCTTGA 30; Taqman Probe:
50 ACAGCCGTAGGCCCAGGTACGACA 30), were designed
from mouse cDNA sequences (Entrez-NIH and Ensembl,
Sanger Institute) using primer express (Applied Biosystems,
Paisley, UK) and obtained from TAG Copenhagen (Copen-
hagen, Denmark). The probe was 50 6-carboxyflouresine
(FAM) and 30 6-carboxy-N, N, N’, N’- tetramethylrho-
damine (TAMRA) labeled. Predeveloped primers and Taq-
man probe were used to detect GAPDH (Applied
Biosystems). A serial dilution was created from a pool of all
samples and used to construct a standard curve to calculate
the mRNA content of PGC-1a and GAPDH in the individ-
ual samples. PGC-1a mRNA was normalized to GAPDH
mRNA content, which was not affected by the intervention
or genotype.
Lysate generation and western blotting
Lysates were generated from ~20 mg of crushed liver as pre-
viously described (Birk and Wojtaszewski 2006) except that
homogenization was performed in a Tissue Lyser (Qiagen,
Hilden, Germany) for 2 min at 30 Hz. Homogenized sam-
ples were left for 1 h at 4°C turning end over end and
lysates were generated by centrifugation at 16000 g, 4°C for
20 min. Protein concentrations of lysates were determined
using the BCA assay (Thermofisher Scientific) and samples
were adjusted to 2 lg/ll in sample buffer containing SDS.
Proteins were separated by SDS PAGE and transferred to a
PVDF membrane by semidry blotting. The membrane was
blocked in 3% fish gel (FG) and probed over night with pri-
mary antibodies recognizing ACC1Ser79 and 2Ser212 phos-
phorylation (#07-303, Millipore, Darmstadt, Germany),
ACC1 and 2 (Streptavidin-HRP, Dako, Denmark), respira-
tory chain complexes I-V (#110413, ABCAM, Cambridge,
UK), PEPCK (#10004943, Cayman chemicals, Ann Abor,
MI), PDK2 (# ST1643, Calbiochem, Millipore), PDK4 (kind
gift from professor Grahame Hardie, University of Dundee,
UK), G6Pase (#27198, Santa Cruz biotechnology, Dallas,
TX) and GAPDH (# 2118, Cell Signaling Technologies, Bev-
erly, MA). The membrane was the following day incubated
in horseradish peroxidase conjugated secondary antibody in
3% FG recognizing the primary antibody. Bands were visu-
alized using chemiluminescence (Luminata class1co/forte
ECl reagent, Millipore, Damstad, Germany) and the Image
Quant LAS 4000 system (GE Healthcare, Hatfield, UK) and
quantified using Image Quant TL (GE Healthcare).
Statistics
All values are presented as mean  standard error of the
mean (SE). Two way analysis of variance (ANOVA) was
used to test effects of intervention and genotype. In addi-
tion, a one-way ANOVA was used to determine the effect
of interventions within each genotype separately. A stu-
dent Newman–Keuls test was used to locate differences
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between groups. If variances were not equal in the two
way ANOVA, a Student’s t-test was used to determine
effects of genotype and if variances were not equal in the
one way ANOVA, an ANOVA on RANKS was used to
test the effect of the intervention. A value of P < 0.05 was
considered significant.
Results
Basal plasma parameters
To investigate if SkM IL-6 affected whole body glucose
metabolism, plasma glucose, lactate, and b-hydroxybuty-
rate levels were determined. Neither HFD, HFD, and
exercise training nor loss of SkM IL-6 affected plasma
glucose, lactate or b-hydroxybutyrate levels (Table 1).
Hepatic glucose, lactate, glycogen, and
triglycerides
To investigate if SkM IL-6 affected liver carbohydrate
metabolism, liver glucose, lactate, glycogen, and triglyc-
erides were investigated. While hepatic glucose concen-
tration was ~30% higher (P < 0.05) in HFD and HFD
ExTr than Chow within IL-6 MKO mice (Fig. 1A), the
lactate concentration did not change with HFD or HFD
combined with exercise training in either genotype
(Fig. 1B). In addition, Floxed mice had ~10% higher
(P < 0.05) hepatic glycogen content in HFD ExTr than
Chow and HFD (Fig. 1C). Hepatic TG content was ~2
fold and ~1.5 fold higher (P < 0.05) in HFD and HFD
ExTr, respectively, than Chow for both genotypes
(Fig. 1D).
Table 1. Plasma concentration of glucose, lactate, and b-hydroxybutyrate in Floxed and IL-6 MKO mice after 16 weeks on Chow, HFD, or
HFD with exercise training (n = 9–10). Values are mean  SE.
Chow HFD HFD ExTr
Floxed IL-6 MKO Floxed IL-6 MKO Floxed IL-6 MKO
Plasma glucose (mmol/l) 5.1  0.2 5.0  0.2 5.1  0.2 5.1  0.2 4.9  0.2 4.8  0.2
Plasma lactate (mmol/l) 4.3  0.3 4.3  0.2 4.7  0.4 3.9  0.3 4.2  0.3 4.3  0.2
Plasma b-hydroxybutyrate (mmol/l) 1.3  0.1 1.4  0.2 1.5  0.1 1.5  0.1 1.4  0.1 1.4  0.1
Figure 1. Hepatic glucose (A), lactate (B), glycogen (C), and triglyceride (TG) (D) content in Floxed and IL-6 MKO mice after 16 weeks on
Chow, HFD or HFD with exercise training (n = 9–10). Values are mean  SE.*Significantly different from Chow within given genotype
(P < 0.05); ¤Significantly different from HFD within given genotype (P < 0.05).
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Hepatic gluconeogenic capacity
To investigate the importance of SkM IL-6 in exercise
training-induced counteraction of changes in key factors
in gluconeogenesis with HFD, the protein content of glu-
coneogenic enzymes and regulators of substrate choice
was measured.
Liver PEPCK protein content was in Floxed mice ~50%
lower (P < 0.05) in HFD and HFD ExTr than Chow and
in IL-6 MKO ~1.2 fold higher (P < 0.05) in HFD than
Chow and ~50% lower (P < 0.05) in HFD ExTr than
HFD (Fig. 2A). Thus, hepatic PEPCK protein content was
~2 fold higher (P < 0.05) in IL-6 MKO than Floxed mice
within the HFD mice.
The content of the G6Pase 36 kDa subunit was
unchanged in HFD and HFD ExTr compared with Chow
in both genotypes. However, liver G6Pase 36 kDa protein
content was ~1.2 fold higher (P < 0.05) in IL-6 MKO
than Floxed mice within HFD ExTr (Fig. 2B). The liver
protein content of G6Pase 40.5 kDa was higher
(P < 0.05) in HFD and HFD ExTr than Chow within IL-
6 MKO mice (Fig. 2C), however no significant differences
were present in PDK2 and PDK4 between groups within
IL-6 MKO mice.
Within Floxed mice, hepatic PDK2 protein content was
~20% lower (P < 0.05) in HFD ExTr than Chow
(Fig. 2D) and hepatic PDK4 protein content was ~50%
lower (P < 0.05) in HFD ExTr than both HFD and Chow
(Fig. 2E).
Hepatic fatty acid metabolism
Phosphorylation and protein content of key factors in
lipogenesis and mitochondrial fatty acid uptake were
determined to examine the effect of SkM IL-6 on fat
metabolism in liver.
ACC1Ser79 phosphorylation in liver was unaltered in
both Floxed and IL-6 MKO mice, whereas ACC1 protein
content was ~20% lower (P < 0.05) in HFD and HFD
ExTr than Chow within Floxed mice. This resulted in
~20% higher (P < 0.05) ACC1Ser79 phosphorylation nor-
malized to ACC1 protein content in HFD and HFD ExTr
than Chow in Floxed mice (Fig. 3A and B) with no
effects in IL-6 MKO mice.
Fatty acid synthase (FAS) protein content in the liver was
~40% lower (P < 0.05) in HFD ExTr than Chow within
Floxed mice (Fig. 3C) with no effects in IL-6 MKO mice.
Hepatic ACC2Ser212 phosphorylation was ~50–70%
lower (P < 0.05) and ACC2 protein content was ~20%
lower (P < 0.05) in HFD and HFD ExTr than Chow in
both genotypes. This caused ACC2Ser212 phosphorylation
normalized to ACC2 protein content to be ~40–50%
lower (P < 0.05) in HFD and HFD ExTr than Chow
(Fig. 3D and E).
Figure 2. Hepatic PEPCK (A), G6Pase 36 kDa (B), G6Pase 40.5 kDa (C), PDK2 (D) PDK4 (E) protein content and representative blots (F) in
Floxed and IL-6 MKO mice after 16 weeks on Chow, HFD or HFD with exercise training (n = 9–10). Values are mean  SE. *Significantly
different from Chow within given genotype (P < 0.05); ¤Significantly different from HFD within given genotype (P < 0.05); #Significantly
different from Floxed mice within given intervention (P < 0.05).
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Neither HFD, HFD and exercise training nor loss of
SkM IL-6 affected the hepatic b-HAD activity (Table 2).
Hepatic mitochondrial capacity
The protein content of respiratory chain complexes and
PGC-1a mRNA content were determined to investigate the
effect of SkM IL-6 on the oxidative capacity of the liver.
Hepatic PGC-1a mRNA content was unaltered in
response to HFD and HFD combined with exercise train-
ing in both genotypes (Fig. 4A).
The protein content of complex I of the respiratory
chain was in the liver of Floxed mice ~20% lower
(P < 0.05) in HFD and HFD ExTr than Chow, but other-
wise no differences were observed in any of the other res-
piratory chain complexes either in Floxed or IL-6 MKO
mice (Fig. 4B, C).
Discussion
The main finding of this study is that SkM IL-6 seems to
contribute to the regulation of markers of gluconeogene-
sis in response to HFD, without playing a major role in
the regulation of hepatic fat metabolism or oxidative
capacity in mice on HFD or HFD combined with exercise
training.
As previously reported (Knudsen et al. 2015) the
increased fat mass and reduced glucose tolerance in the
mice from this study demonstrate that the 16 weeks of
HFD were effective although total body weight and insulin
tolerance were unaffected. In addition, the previously pub-
lished observation (Knudsen et al. 2015) that both geno-
types reduced fat mass when HFD was combined with
exercise suggests that the exercise training protocol did
counteract some effects of the HFD. The present finding
Figure 3. Hepatic ACC1Ser79 phosphorylation normalized to ACC1 protein content (A), ACC1 protein content (B), FAS protein content (C),
ACC2Ser212 phosphorylation normalized to ACC2 protein content (D), ACC2 protein content (E) and representative blots (F) in Floxed and IL-6
MKO mice after 16 weeks on Chow, HFD or HFD with exercise training (n = 9–10). Values are mean  SE. *Significantly different from Chow
within given genotype (P < 0.05).
Table 2. Hepatic HAD activity in Floxed and IL-6 MKO mice after 16 weeks on Chow, HFD, or HFD with exercise training (n = 5–8). Values
are mean  SE.
Chow HFD HFD ExTr
Floxed IL-6 MKO Floxed IL-6 MKO Floxed IL-6 MKO
HAD activity (mmol/min/mg protein) 5.5  0.8 6.3  0.8 5.6  1.0 4.5  0.9 4.7  1.0 4.3  0.8
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that ACC2 phosphorylation was decreased in Floxed mice
with 16 weeks of HFD feeding, without changes in insulin
tolerance (Knudsen et al. 2015), may suggest that the liver
was using glucose rather than FA as substrate for oxidation
when the mice were on HFD. Furthermore, the increased
ACC1 phosphorylation and reduced PEPCK protein con-
tent in the Floxed mice on HFD may suggest that de novo
lipogenesis and gluconeogenic capacity were reduced with
HFD feeding. Together these findings strongly suggest that
the 16 weeks of HFD changed the regulation of hepatic
metabolism. Furthermore, the exercise training-induced
increase in hepatic glycogen content and decrease in PDK4
and PDK2 protein content in Floxed mice provide evi-
dence for exercise training-induced modifications of hep-
atic carbohydrate metabolism when on a HFD. These
results also indicate that HFD combined with exercise
training caused the liver to become more dependent on
glucose as substrate than HFD alone. Additionally, the
observation that exercise training reduced hepatic FAS
protein content in Floxed mice on HFD further supports
that the exercise training protocol used in this study
induced changes in hepatic metabolism.
The hypothesis of this study was that SkM IL-6 plays a
role in the exercise training-induced counteraction of
changes in liver carbohydrate and lipid metabolism caused
by HFD. The present observations that glucose accumu-
lated in the liver of IL-6 MKO mice in response to HFD
may suggest an impairment of intrahepatic glucose han-
dling when SkM IL-6 was lacking. Accordingly, PEPCK
protein content was increased in response to HFD in IL-6
MKO mice suggesting that the increased intrahepatic glu-
cose content in IL-6 MKO mice may be a result of an
increased gluconeogenic activity. The increased level of
PEPCK in IL-6 MKO mice on HFD indicates that SkM IL-
6 is required for the reduction in hepatic PEPCK protein
content observed with HFD. This is in contrast to the pre-
vious findings that injection of IL-6 leads to increased
PEPCK mRNA (Banzet et al. 2009) but this observation
was made in chow fed rats and it could be suggested that
either species or diet may influence the effect of IL-6. The
observations that G6Pase 36 kDa protein content increased
in IL-6 MKO mice compared with Floxed mice and
G6Pase 40.5 kDa increased only in IL-6 MKO mice with
HFD and HFD ExTr support that gluconeogenic capacity
may have been higher in IL-6 MKO than Floxed mice
when on HFD and HFD ExTr. At the same time, the simi-
lar PDK2 and 4 protein content in IL-6 MKO and Floxed
mice suggests that skeletal muscle IL-6 did not influence
basal hepatic carbohydrate oxidation. As the plasma glu-
cose and hepatic glycogen content was similar in chow,
HFD and HFD ExTr within IL-6 MKO mice, it may be
speculated that an impairment in glucose transport out of
the liver contributed together with an enhanced gluconeo-
genesis lead to the increased hepatic glucose concentration
in IL-6 MKO mice on HFD.
It has previously been shown that whole body IL-6 KO
mice have a reduced capacity for hepatic b-oxidation
when on HFD (Matthews et al. 2010). The present find-
ing that both Floxed and IL-6 MKO mice had reduced
ACC2Ser212 phosphorylation when on HFD suggests that
there was a higher potential for uptake of FA in to mito-
chondria in the liver independent of SkM IL-6.
The observed increase in ACC1Ser79 phosphorylation in
response to HFD and HFD combined with exercise only
Figure 4. Hepatic PGC-1a mRNA content (A) and respiratory chain
complex protein content (B,C) in Floxed and IL-6 MKO mice after
16 weeks on Chow, HFD or HFD with exercise training (n = 9–10).
Values are mean  SE. *Significantly different from Chow within
given genotype (P < 0.05).
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in Floxed mice may on the other hand raise the possibil-
ity that SkM IL-6 alters ACC1 activity. As the major role
of ACC1 is considered to be production of malonyl-CoA
for FA synthesis (Abu-Elheiga et al. 2005), it may be
speculated that this reflects that lipogenesis was increased
with HFD and HFD ExTr in an IL-6-dependent manner.
However, as ACC1 protein content was decreased in
floxed mice on HFD and HFD combined with exercise
training, the amount of active ACC1 protein would be
lower in mice on HFD and HFD ExTr than on chow, and
thus indicate that lipogenesis was in fact decreased rather
than increased in a skeletal muscle IL-6-dependent man-
ner. This is also supported by the reduction in FAS pro-
tein content in HFD ExTr in Floxed mice. However, the
similar increase in hepatic TG content with HFD and
HFD ExTr in the two genotypes, does not provide evi-
dence that SkM IL-6 plays a major role in the regulation
of liver TG accumulation in response to HFD with or
without exercise training.
The present findings that SkM IL-6 deficiency had no
effect on oxidative capacity in the liver do not support
previous observations that oxidative capacity was reduced
with HFD in whole body IL-6 Knockout mice (Matthews
et al. 2010). Rather, IL-6 MKO mice seemed to be pro-
tected from the mild reduction in complex I observed in
Floxed mice in response to HFD. However, it may be
speculated that redundancy via IL-6 released from other
tissues could explain the discrepancies between the pre-
sent and previous findings (Matthews et al. 2010).
In conclusion, these results suggest that SkM IL-6 is
contributing to decreased hepatic glucose production in
response to HFD through regulation of hepatic PEPCK
and G6Pase protein content. However, SkM IL-6 does
not seem to be of major importance for oxidative capac-
ity, lipogenesis or the regulation of mitochondrial fatty
acid uptake in liver during HFD or HFD combined with
exercise training
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